VIM and colorectal carcinoma: Our results showed that AIM2 inhibited CRC cell migration and reversed EMT progress as evidenced by the fact that disruption of AIM2 inhibited E-cadherin expression and promoted Vimentin expression while AIM2 overexpression did the opposite in CRC cells, which is consistent with the previous study [17].